Form D · Other Health Care
Phenomix Sciences, Inc.
Menlo Park, CA · CIK 0001966746
Offering snapshot reported Dec 29, 2025 · SEC filing
- Reported sold
- $2.5M Offering amount: $5M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 23, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 29, 2025 | Initial | $2,500,002 | No comparison | 4 | SEC filing |
| May 6, 2024 | Initial | $5,000,000 | No comparison | 4 | SEC filing |
| Feb 22, 2023 | Initial | $1,049,998 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-568274
Source: Form D, filed Dec 29, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Andres Acosta | Director |
| Mark Bagnall | Director, Executive |
| Mark Bengall | Director, Executive |
| Michael Camilleri | Director |
| Lawrence Cohen | Director |
| Karl Ronn | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
3000 Sand Hill Rd. Ste. 3 210
Menlo Park, CA, 94025
Menlo Park, CA, 94025